AstraZeneca launches its new diabetes drug Onglyza
The world’s seventh-largest pharma company, AstraZeneca Pharma and biopharmaceutical firm Bristol-Myers Squibb have launched their 9-month-old diabetes drug Onglyza in India – the biggest market for the drug.
This entry was posted
on Monday, May 17th, 2010 at 2:47 pm and is filed under Diabetes.
You can follow any responses to this entry through the RSS 2.0 feed.
You can leave a response, or trackback from your own site.
